News

Infleqtion, Inc. (NYSE:INFQ) announced a joint research and development collaboration with Cisco Systems, Inc. (NASDAQ:CSCO) on September 10, 2026, to connect, operate, and scale quantum systems into distributed networks. By linking Infleqtion’s neutral-atom quantum processors and sensors with Cisco’s quantum networking stack, the companies aim to transition standalone quantum hardware into scalable, interconnected networks. As […]

It was reported on September 11 that Apollo Global Management, Inc. (NYSE:APO) is in discussions to acquire Johnson & Johnson (NYSE:JNJ)’s orthopedics business, DePuy Synthes, in a potential transaction valuing the unit at close to $20 billion, according to Bloomberg. The unit, which J&J previously announced plans to separate within an 18-to-24-month timeframe, generated $9.3 […]

Today, Sept. 24, 2026, the enterprise cloud giant filed to shield itself from cost and payment risk as the New Mexico facility faces public opposition and permitting delays.

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the afternoon session after The U.S. Food and Drug Administration approved Eli Lilly’s once-weekly basal insulin, Onswik, for adults with type 2 diabetes, giving patients an alternative to daily long-acting insulin shots. According to Reuters, Lilly said Onswik — chemically known as insulin efsitora alfa-gobe — is intended to be used with diet and exercise to help control high blood sugar and could cut the number of inje

With the S&P 500 trading at stretched valuations, one lesser-known ETF takes a completely different approach to generating income, one that doesn't depend on stocks continuing to climb.

Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.

SPY looks dirt cheap at a fraction of a percent, but a hidden structural quirk quietly siphons money from long-term holders in a way the fund's own fact sheet never spells out.

It isn't about return optimization, but about optimizing for your own financial situation.

McDonald's (MCD) has a pricing problem in the United States, its second-largest business. Its value menu of 10 items for under $3 each has not delivered what management expected. The shares lost 19.3% over the past year (as of September 23, 2026), while the S&P 500 returned 13%. The fix is not settled, because it depends on franchisees charging the prices McDonald's recommends.

Boeing trades at a 49.7x forward P/E versus Lockheed's 17.3x, but one carries turnaround upside while the other offers fortress-like stability.

A number of stocks fell in the afternoon session after investors kept pricing in higher borrowing costs from the Federal Reserve’s recent rate hike and the lasting pressure that tighter policy puts on private-market dealmaking and exits. According to Morningstar, elevated policy rates create headwinds for private equity firms by lifting floating-rate interest expense and worsening exit bottlenecks. More expensive leverage can slow deal activity and make portfolio-company sales harder to complete

Growth stocks dominated for years, but 2026 has handed dividend ETFs an unexpected edge, and three funds yielding over 3% are proving the rotation is real. The question is whether you own the right one for what comes next.

LPL Financial Holdings Inc. (NASDAQ:LPLA) is the largest independent broker-dealer in the U.S. The company offers custody, technology, and operational infrastructure to independent financial advisors. On September 22, 2026, the stock fell 7.5% to $307.50, the day’s one of the biggest large-cap drops, and trades at 23% below its 52-week high of $400.16. Two things […]

Airbnb (ABNB) shares fell 21% in the month to September 23, while the S&P 500 rose 0.8%. A $10,000 holding at the start of that month was worth about $7,860 at the end. Airbnb's own news over those weeks does not explain it, so the fall needs a different explanation.

CEO Mike Doustdar spoke openly about a risk facing Wegovy and Ozempic, and Wall Street’s growth expectations for Novo shifted quickly.

Micron has handed investors a spectacular run, but concentrating that bet on one company's fab schedule carries risks that most MU bulls haven't fully priced in. A $26 billion fund quietly packages the entire memory oligopoly into a single ticker, and it just got cheaper.

Coinbase Global Inc. CEO Brian Armstrong pushed back against AI doomsday warnings, arguing that slowing AI progress could delay technologies that might help prevent deaths. Armstrong Defends AI Progress On Tuesday, in a post on X, Coinbase CEO addressed AI...

A number of stocks fell in the morning session after benchmark 10-year U.S. Treasury yields rose above 5.1%, renewing pressure on high-multiple technology valuations.

A number of stocks fell in the morning session after benchmark 10-year U.S. Treasury yields rose above 5.1%, renewing pressure on high-multiple technology valuations. The pullback follows a six-session climb that had lifted the Philadelphia Semiconductor Index by 14% since the start of the week, according to Nasdaq index data.

Investors love accelerating growth.

On Sept. 24, 2026, the security software maker beat Q2 estimates and raised its full-year outlook, citing automotive design wins and 26% revenue growth.

The memory chip market is historically cyclical, but there's hope for a smoother future.

The space company wants to rapidly boost revenue over the next few years, betting its huge rockets will make it a powerful industry player.

The capital requirement to generate nearly $8,000 a month for life swings by more than $1.7 million depending on the yield strategy a 62-year-old chooses, and the cheaper-looking option often destroys the retirement it was supposed to fund.

One of these numbers could double in November -- on paper.

SpaceX will see its weight double in the Nasdaq-100.

New restaurants give McDonald's (MCD) more growth than its weak U.S. results suggest. Value meals and slow visits are part of the story, but not all of it. McDonald's shares fell 4.8% on September 23, the day the company laid out a new plan at its Investor Day. The price appears to reflect the U.S. troubles and the plan's cost. So how much are the new restaurants actually adding.

The company's latest electric vehicle will attract a huge amount of attention, but it's what's going on behind the scenes that really matters.

Rising UK borrowing costs, highlighted by the recent jump in 10 year gilt yields ahead of the next budget, are forcing investors to think harder about where future growth could come from. That is one reason artificial intelligence in healthcare is getting more attention. This piece looks at three UK focused AI healthcare stocks from our screener that aim to tap into this shift and explains what each one offers. The three stocks covered below are just a sample, and the full screen surfaced 5...

Novo Nordisk trades at a steep discount on earnings and sales, while AbbVie grapples with patent cliffs and pricing pressure, but profitability tells a different story.